|
MTMR6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.33549999999472E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.282010E-03 |
| Normal-vs-Stage2 |
2.432600E-01 |
| Normal-vs-Stage3 |
4.05599999997452E-06 |
| Normal-vs-Stage4 |
7.222600E-03 |
| Stage1-vs-Stage2 |
6.808800E-01 |
| Stage1-vs-Stage3 |
1.895550E-02 |
| Stage1-vs-Stage4 |
3.721400E-01 |
| Stage2-vs-Stage3 |
1.079150E-01 |
| Stage2-vs-Stage4 |
3.453400E-01 |
| Stage3-vs-Stage4 |
5.205600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.41660000000121E-05 |
| Normal-vs-AfricanAmerican |
1.895500E-03 |
| Normal-vs-Asian |
6.713000E-01 |
| Caucasian-vs-AfricanAmerican |
5.342600E-01 |
| Caucasian-vs-Asian |
4.898000E-01 |
| AfricanAmerican-vs-Asian |
3.031000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.63640000000665E-05 |
| Normal-vs-Female |
1.855780E-03 |
| Male-vs-Female |
4.748800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.79340000000017E-05 |
| Normal-vs-Age(41-60Yrs) |
5.124000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.23909999998995E-05 |
| Normal-vs-Age(81-100Yrs) |
3.770100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.037800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.755400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.882200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.997800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.811000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.397000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.613000E-01 |
| Normal-vs-Grade 2 |
2.438100E-02 |
| Normal-vs-Grade 3 |
2.28229999998941E-06 |
| Normal-vs-Grade 4 |
2.355100E-04 |
| Grade 1-vs-Grade 2 |
7.220000E-01 |
| Grade 1-vs-Grade 3 |
1.948190E-01 |
| Grade 1-vs-Grade 4 |
1.760150E-01 |
| Grade 2-vs-Grade 3 |
3.231700E-02 |
| Grade 2-vs-Grade 4 |
2.372100E-02 |
| Grade 3-vs-Grade 4 |
3.585600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.402550E-01 |
| Normal-vs-ccB subtype |
1.83482999999152E-05 |
| ccA subtype-vs-ccB subtype |
2.301400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.003300E-03 |
| Normal-vs-N1 |
2.758000E-01 |
| N0-vs-N1 |
8.679600E-01 |
|
|
